Robert Thomas Freeman Sells 6,744 Shares of Alignment Healthcare, Inc. (NASDAQ:ALHC) Stock

Alignment Healthcare, Inc. (NASDAQ:ALHC) CFO Robert Thomas Freeman sold 6,744 shares of the stock in a transaction that occurred on Thursday, March 27th. The shares were sold at an average price of $17.89, for a total transaction of $120,650.16. Following the completion of the transaction, the chief financial officer now owns 1,464,419 shares in the company, valued at $26,198,455.91. This represents a 0.46 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.

Robert Thomas Freeman also recently made the following trade(s):

• On Tuesday, March 18th, Robert Thomas Freeman sold 13,815 shares of Alignment Healthcare stock. The shares were sold at an average price of $16.89, for a total transaction of $233,335.35.
• On Wednesday, March 12th, Robert Thomas Freeman sold 14,692 shares of Alignment Healthcare stock. The shares were sold at an average price of $15.43, for a total transaction of $226,697.56.
• On Thursday, March 6th, Robert Thomas Freeman sold 218,295 shares of Alignment Healthcare stock. The stock was sold at an average price of $15.53, for a total value of $3,390,121.35.
• On Tuesday, March 4th, Robert Thomas Freeman sold 250,000 shares of Alignment Healthcare stock. The shares were sold at an average price of $15.58, for a total value of $3,895,000.00.

Alignment Healthcare Trading Up 0.9 %

NASDAQ ALHC opened at $18.30 on Friday. Alignment Healthcare, Inc. has a 52-week low of $4.46 and a 52-week high of $18.44. The firm has a 50-day moving average price of $15.28 and a 200 day moving average price of $13.00. The stock has a market capitalization of $3.51 billion, a P/E ratio of -23.77 and a beta of 1.49. The company has a quick ratio of 1.60, a current ratio of 1.60 and a debt-to-equity ratio of 1.82.

Wall Street Analysts Forecast Growth

Several research analysts have commented on ALHC shares. Stephens reaffirmed an “overweight” rating and set a $17.00 price target on shares of Alignment Healthcare in a research report on Monday, February 24th. Barclays lifted their target price on shares of Alignment Healthcare from $8.00 to $9.00 and gave the company an “underweight” rating in a report on Friday, February 28th. Piper Sandler increased their price target on shares of Alignment Healthcare from $14.00 to $21.00 and gave the stock an “overweight” rating in a research note on Tuesday, March 4th. William Blair restated an “outperform” rating on shares of Alignment Healthcare in a research note on Friday, February 28th. Finally, JPMorgan Chase & Co. increased their target price on shares of Alignment Healthcare from $14.00 to $17.00 and gave the stock a “neutral” rating in a research note on Thursday, March 6th. One analyst has rated the stock with a sell rating, three have assigned a hold rating, seven have assigned a buy rating and one has given a strong buy rating to the company. According to MarketBeat, Alignment Healthcare presently has a consensus rating of “Moderate Buy” and an average price target of $14.83.

Hedge Funds Weigh In On Alignment Healthcare

A number of large investors have recently modified their holdings of the business. Connor Clark & Lunn Investment Management Ltd. acquired a new position in Alignment Healthcare during the third quarter worth $131,000. Intech Investment Management LLC acquired a new position in shares of Alignment Healthcare during the 3rd quarter worth $315,000. Charles Schwab Investment Management Inc. grew its stake in shares of Alignment Healthcare by 1.7% during the 3rd quarter. Charles Schwab Investment Management Inc. now owns 839,695 shares of the company’s stock worth $9,925,000 after purchasing an additional 13,865 shares during the period. Algert Global LLC increased its holdings in shares of Alignment Healthcare by 44.8% in the 3rd quarter. Algert Global LLC now owns 80,903 shares of the company’s stock valued at $956,000 after purchasing an additional 25,050 shares in the last quarter. Finally, The Manufacturers Life Insurance Company lifted its stake in shares of Alignment Healthcare by 132.2% in the third quarter. The Manufacturers Life Insurance Company now owns 128,933 shares of the company’s stock valued at $1,524,000 after purchasing an additional 73,402 shares during the period. 86.19% of the stock is owned by hedge funds and other institutional investors.

Alignment Healthcare Company Profile

Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.